✦ LIBER ✦

O-50 Gemcitabine plus vinorelbine (GV) or paclitaxel (GT) vs. gemcitabine (G) or paclitaxel (T) alone in elderly or unfit NSCLC patients: A SICOG 9909 phase III trial

✍ Scribed by Comella, Pasquale; Del Gaizo, Filomena; Gambardella, Antonio; Frasci, Giuseppe; De Cataldis, Giuseppe; Panza, Nicola; Buzzi, Franco; Muci, Domenico; De Lena, Mario; Comella, Giuseppe

Book ID: 118571441
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 180 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91708-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine + vinorelbine (GV) vs vinore

Gemcitabine + vinorelbine (GV) vs vinorelbine (V) alone in elderly or frail non-small cell lung cancer (NSCLC) patients. Interim analysis of a SICOG phase III trial

✍ G. Frasci; V. Lorusso; N. Panza; G. DeCataldis; F. Del Gaizo; G.P. Nicolella; V. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

O-217 A randomized phase III trial of ge

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB